Serum creatinine concentration, the classical biomarker of chronic kidney disease (CKD) in
cats, has important limitations that decrease its value as a biomarker of early CKD. Recently,
serum symmetric dimethylarginine concentration was introduced as a novel glomerular
filtration rate biomarker for the early detection of CKD in cats. However, data on its specificity
are still limited. The limitations of conventional biomarkers and the desire for early
therapeutic intervention in cats with CKD to improve outcomes have prompted the discovery …

抄録 Serum creatinine concentration, the classical biomarker of chronic kidney disease
(CKD) in cats, has important limitations that decrease its value as a biomarker of early CKD.
Recently, serum symmetric dimethylarginine concentration was introduced as a novel
glomerular filtration rate biomarker for the early detection of CKD in cats. However, data on
its specificity are still limited. The limitations of conventional biomarkers and the desire for
early therapeutic intervention in cats with CKD to improve outcomes have prompted the …